Voluntis

News

Aptar makes digital health play, agreeing deal to buy Volunt...

Drug delivery specialist Aptar Group has agreed a deal to take a near two-thirds share in Voluntis, a French developer of digital therapeutics (DTx), with a view to taking full control of t

News

Diabetes - diagnosis written on a white piece of paper. Syringe and vaccine with drugs.

Biocon annouces digital diabetes tie-up with Voluntis

Biocon has announced a deal with digital therapy specialist Voluntis, aiming to create personalised care for people with type 2 diabetes taking biosimilar insulins.

News

BMS joins with Voluntis to create cancer support app

Bristol-Myers Squibb has joined with digital therapeutics firm Voluntis to create an app that will support cancer patients.

Digital

Expanding the definition of medicine

Digital therapeutics are adding new elements to the medical world, but their place in the pharmaceutical sector is not yet fully established.

News

Roche Ieso digital health therapeutics mental health

Roche Diabetes Care partners with digital therapeutics firm ...

Roche’s diabetes arm is working with Ieso Digital Health to test the Cambridge, UK-based digital therapeutics firm’s mental health programme in type 2 diabetes patients in the UK and Irelan